Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

HHS Accessibility Requirements for Medical Diagnostic Equipment: What Health Care Providers Need to Know

Client Alert

The U.S. Department of Health and Human Services (HHS), through its Office for Civil Rights, has adopted updated accessibility requirements for medical diagnostic equipment under Section 504 of the Rehabilitation Act.[1] These requirements are intended to reduce barriers to care for individuals with disabilities and to ensure that covered providers offer services in a manner that is accessible and nondiscriminatory.

For health care providers that receive federal financial assistance, including providers participating in Medicare, Medicaid, CHIP, or other HHS-funded programs, the rule creates specific obligations regarding accessible medical diagnostic equipment (MDE), staff preparedness, and program accessibility. In practice, the rule is aimed at ensuring that patients with disabilities can receive routine examinations and diagnostic services using equipment that is accessible and usable.

Key takeaways from the updated rule include the following:

  • The rule adopts accessibility standards for medical diagnostic equipment, including examination tables, examination chairs, weight scales, mammography equipment, and certain radiological equipment.
  • Providers must ensure that their services are accessible in practice, even if a particular office or location does not yet have all required accessible equipment in place. If needed, the provider may need to arrange care at a hospital or another accessible practice location.
  • Covered entities must have qualified staff who can operate accessible equipment and assist patients with transfers and positioning as needed.
  • The rule also strengthens broader disability nondiscrimination protections affecting digital accessibility and other health and human services activities. 

Under the rule, each covered provider that uses examination tables and weight scales must have at least one accessible examination table and one accessible weight scale in place by July 8, 2026. Beyond that baseline requirement, covered providers generally must ensure that at least 10% of each type of medical diagnostic equipment is accessible, with a minimum of one accessible unit. For providers that specialize in treating conditions affecting mobility, such as rehabilitation centers and physical therapy practices, the threshold increases to 20%. 

With the July 8, 2026 compliance deadline now here for HHS-funded recipients, providers should assess current equipment inventories, identify whether accessible examination tables and weight scales are available at each relevant location, review purchasing practices, and train staff on equipment use and patient assistance protocols. Providers that fail to comply may face enforcement risk, including administrative action and potential litigation exposure. 

For many providers, this is not simply an equipment procurement issue. It is also an operational compliance issue that requires coordination across facilities, purchasing, clinical operations, and staff training. Covered entities should consider acting now to confirm that their accessibility practices align with the updated Section 504 requirements. 

For questions regarding the updated MDE accessibility requirements or assistance with compliance and implementation, please contact Vice President and Akron Managing Partner Amanda Waesch at alwaesch@bmdllc.com

[1] 29 U.S.C. §794.


Don't Get Caught Dazed and Confused: Another Florida Court Weighs in on Employer Obligations to Accommodate Medical Marijuana Use

A Florida trial court ruled in Giambrone v. Hillsborough County that employers may need to accommodate off-duty medical marijuana use under the Florida Civil Rights Act (FCRA). This contrasts with prior rulings and raises new compliance challenges for employers. With the case on appeal, now is the time to review workplace drug policies.

Corporate Transparency Act to be Re-evaluated

Recent federal rulings have impacted the enforceability of the Corporate Transparency Act (CTA), which took effect on January 1, 2024. While reporting requirements were briefly reinstated, FinCEN has now paused enforcement and is reevaluating the CTA. Businesses are no longer required to submit reports until further guidance is issued. For updates and legal counsel, contact BMD Member Blake Gerney.

Ohio Recovery Housing Operators Beware: House Bill 58 Seeks to Make Major Changes

Ohio House Bill 58 proposes significant changes to recovery housing oversight, granting ADAMH Boards authority to inspect and investigate recovery residences. The bill also introduces a Certificate of Need (CON) program, requiring state approval for major facility changes. OMHAS will assess applications based on cost, quality, accessibility, and financial feasibility. The bill also establishes a recovery housing residence fund to support inspections. For more information, contact BMD attorneys Daphne Kackloudis or Jordan Burdick.

January 2025 Notice of Proposed Rulemaking Brings Notable Changes to HIPAA Security Rule

In January 2025, the U.S. Department of Health and Human Services proposed amendments to the HIPAA Security Rule, aiming to enhance cybersecurity for covered entities (CEs) and business associates (BAs). Key changes include mandatory compliance audits, workforce training, vulnerability scans, and risk assessments. Comments on the proposed rule are due by March 7, 2025.

Corporate Transparency Act Effective Again

The federal judiciary has issued multiple rulings on the enforceability of the Corporate Transparency Act (CTA), which took effect on January 1, 2024. Previously, enforcement was halted nationwide due to litigation in Smith v. U.S. Department of the Treasury. However, on February 18th, the court lifted the stay, reinstating the CTA’s reporting requirements. Non-exempt entities now have until March 21, 2025, to comply. Businesses should act promptly to avoid civil penalties of $591 per day and potential criminal liability.